Patricia Babbitt
American pharmaceutical chemist
From Wikipedia, the free encyclopedia
Patricia Clement Babbitt is a Professor and Principal Investigator (PI) in the school of pharmacy at the University of California, San Francisco (UCSF).[2][4][5][6][7][8]
Patricia Babbitt | |
|---|---|
| Born | Patricia Clement Babbitt |
| Education | University of California, San Francisco (PhD) |
| Awards | ISCB Fellow (2018)[1] |
| Scientific career | |
| Fields | Bioinformatics[2] Computational biology[2] |
| Workplaces | University of California, San Francisco |
| Thesis | Sequence determination, expression, and site-directed mutagenesis of creatine kinase (1988) |
| George L. Kenyon[3] Irwin Kuntz[3] | |
| Website | profiles |
Education
Patricia Babbitt earned a PhD in pharmaceutical chemistry in 1988 from the University of California, San Francisco[3][4] for research supervised by George L. Kenyon and Irwin Kuntz.[3]
Career and research
Babbitt serves as the director of the UCSF bioinformatics and medical informatics graduate program.[citation needed] She also serves on the advisory boards for the UniProt, InterPro[9] and MetaCyc databases, the Howard Hughes Medical Institute (HHMI) scientific review board, and as a deputy editor for PLOS Computational Biology.[10] Her research interests include bioinformatics and computational biology.[2][8][11]
Awards and honors
Babbitt was elected a Fellow of the International Society for Computational Biology (ISCB) in 2018 for “outstanding contributions to the fields of computational biology and bioinformatics”.[1]
